NVAX · Insider trading · 13F holders · Congress trades
Novavax, Inc. (NVAX)
Who is buying and selling NVAX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 6
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 2
NVAX at a glance
- No open-market insider purchases or sales of NVAX were filed in the last 90 days.
- 6 13F filers hold NVAX among their 50 largest positions, worth $254.2M combined, including Philippe Laffont. The biggest bets by portfolio weight are Shah Capital Management (21.7%), Sanofi (12.1%) and TSP Capital Management Group, LLC (3.9%).
- Members of Congress have disclosed 2 NVAX trades since 2020, 1 purchase and 1 sale in the past year; the latest was Pat Roberts (R-KS), selling $1K–15K on Oct 13, 2020.
- NVAX last closed at $10.33 on Oct 30, 2026.
NVAX insider trading
No open-market insider purchases or sales of NVAX were filed in the last 90 days.
Who owns NVAX? Hedge funds and superinvestors
6 13F filers hold NVAX among their 50 largest positions, worth $254.2M combined, including Philippe Laffont. The biggest bets by portfolio weight are Shah Capital Management (21.7%), Sanofi (12.1%) and TSP Capital Management Group, LLC (3.9%).
Superinvestors holding NVAX: Philippe Laffont 0.1%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Shah Capital ManagementHedge fund | 21.7% | $131.6M | 12,173,481 | -14.1% shares | Q3 2026 |
| SanofiCorporation | 12.1% | $64.8M | 6,880,481 | +0.0% shares | Q2 2026 |
| Philippe LaffontInvestment manager | 0.1% | $36.1M | 3,836,986 | +0.0% shares | Q2 2026 |
| TSP Capital Management Group, LLCWealth manager | 3.9% | $15.5M | 1,432,365 | +0.9% shares | Q3 2026 |
| Monaco Asset Management SAMAsset manager | 2.0% | $5.4M | 577,464 | -17.2% shares | Q2 2026 |
| Ares Systematic Credit LtdHedge fund | 1.4% | $755K | 80,155 | -10.5% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 2, Q2 2026: 4). Screen NVAX in the grand portfolio →
NVAX stock trades by members of Congress
Members of Congress have disclosed 2 NVAX trades since 2020, 1 purchase and 1 sale in the past year; the latest was Pat Roberts (R-KS), selling $1K–15K on Oct 13, 2020.
| Filed | Member | Trade | Amount | Traded | Since |
|---|---|---|---|---|---|
| Nov 5, 2020 | Pat RobertsR-KS · Senate | Sale | $1K–15K | Oct 13, 2020 | -91.2% |
| Aug 30, 2020 | Pat RobertsR-KS · Senate | Buy | $1K–15K | Aug 17, 2020 | -93.4% |
NVAX questions and answers
Are insiders buying NVAX stock?
No open-market insider purchases or sales of NVAX were filed in the last 90 days.
Which hedge funds own NVAX?
6 13F filers hold NVAX among their 50 largest positions, worth $254.2M combined, including Philippe Laffont. The biggest bets by portfolio weight are Shah Capital Management (21.7%), Sanofi (12.1%) and TSP Capital Management Group, LLC (3.9%).
Has Congress traded NVAX?
Members of Congress have disclosed 2 NVAX trades since 2020, 1 purchase and 1 sale in the past year; the latest was Pat Roberts (R-KS), selling $1K–15K on Oct 13, 2020.
Who is the largest holder of NVAX?
Among 13F filers, Shah Capital Management reports the largest NVAX position, $131.6M (12,173,481 shares) in its Q3 2026 13F. The biggest bet by portfolio weight is Shah Capital Management's: 21.7% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.